Search

everythinglearnresearchcommunity

for

Search:↓

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

White hairs often regrow in alopecia areata patches.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Alopecia areata affects quality of life more in adolescents than adults.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Higher CRBP1 levels are linked to more severe alopecia areata.